News from myos rens technology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 17, 2020, 08:00 ET MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding

MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada...


Nov 12, 2020, 16:30 ET MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger

MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada...


Nov 06, 2020, 10:00 ET MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020

MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Sep 09, 2020, 08:00 ET MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance

MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), "The Muscle Health Company" and owner of the advanced nutrition supplement Fortetropin®,...


Jul 16, 2020, 08:00 ET MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.

MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Jul 07, 2020, 08:00 ET University of California, Berkeley Researchers Publish Clinical Results Reporting that Fortetropin® Increased the Rate of Muscle Protein Synthesis in Older Adults

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a...


Jun 30, 2020, 16:41 ET MYOS RENS Technology and MedAvail Inc. Announce Merger and Spin-Out of Muscle Health Business

MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition...


Jun 04, 2020, 08:00 ET MYOS RENS Launches RACE-Approved Continuing Education Course for Veterinarians on June 10, 2020

MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that...


May 27, 2020, 08:00 ET MYOS Announces Distribution Agreement with BodyLogicMD, a Leading Nationwide Network of Anti-Aging Medical Practices

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


May 21, 2020, 08:00 ET MYOS RENS Partners with GetHealthy.store to Promote MYOS Longevity's Clinically-Backed Nutrition Products

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


May 14, 2020, 08:00 ET MYOS RENS Enters into Agreement with Victor Medical to Distribute MYOS Canine Muscle Formula® Across Western United States

MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that...


May 08, 2020, 08:00 ET MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues

Company Conference Call: Today, May 8, 2020, at 11:30 AM ET Dial In: 877-407-9120 from the U.S.; International callers may telephone 412-902-1009...


May 04, 2020, 08:00 ET MYOS RENS Technology Announces the Date for First Quarter 2020 Conference Call and Webcast

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Apr 15, 2020, 08:00 ET MYOS RENS Announces Publication of Landmark Clinical Study on Recovery in Dogs Following TPLO Surgery

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a...


Mar 19, 2020, 08:00 ET MYOS RENS Technology Announces Date of Fourth Quarter 2019 Financial Results, Conference Call and Webcast

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Mar 10, 2020, 08:00 ET MYOS RENS Announces Distribution and Co-Marketing Agreement with KVP International, a Leading Distributor of Veterinary Rehabilitation Products

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


Feb 06, 2020, 09:00 ET MYOS RENS Hires College Football Icon and Inspirational Speaker Eric LeGrand as a Special Advisor for its YOLKED® Sports Nutrition Brand

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


Jan 30, 2020, 07:00 ET MYOS Announces Distribution Partnership for Their Blockbuster Canine Muscle Formula with Chewy, a Leading Online Retailer of Pet Food and Pet-Related Products

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


Jan 15, 2020, 07:00 ET MYOS RENS Technology to Provide Exciting Updates on New Product and Clinical Research at the Veterinary Meeting & Expo in Orlando, January 19-22, 2020

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive...


Jan 09, 2020, 07:00 ET MYOS CEO Joseph Mannello Issues Letter to Shareholders

MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Dec 10, 2019, 07:01 ET MYOS to Introduce its Longevity Business with its Physician Muscle Health Formula at the World Congress on Anti-Aging Medicine in Las Vegas December 13-15, 2019

MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Nov 14, 2019, 07:00 ET MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders Summarizing Milestone Achievements and Ongoing Growth Strategy

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


Nov 07, 2019, 17:14 ET MYOS RENS Technology Reports Third Quarter 2019 Financial Results Including Year-Over-Year Revenue Growth of 430%

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, an innovative...


Nov 05, 2019, 07:00 ET MYOS RENS Technology Launches Exclusive 'Veterinarian Strength' Myos Canine Muscle Formula

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, the unique...


Oct 31, 2019, 06:00 ET MYOS RENS Technology Announces the Date for the Release of Third Quarter 2019 Financial Results, Conference Call and Webcast

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...